2016 year in review: Miracles do happen

For me personally, the drought of seeing the Chicago Cubs actually win the World Series and seeing the joy of my patients who have suffered even longer than me is just the icing on the cake to a great year for the ophthalmic industry in 2016. Thirteen years of having only one topical dry eye medication finally ended with an alternative for those 33 million-plus patients suffering from chronic dry eye disease. Patients with progressive keratoconus and corneal ectasia finally have a treatment other than corneal transplantation. Those patients with presbyopia who hate their “age syndrome” finally have an array of corneal inlays as a possible solution until they develop cataracts. And those patients with clinically significant cataracts finally have a new category of presbyopia-correcting IOL known as extended depth of focus to fulfill a vast array of activities of daily living needs. To close the year, patients who undergo cataract surgery with early stages of glaucoma finally now have more options to treat their condition with newer microincisional glaucoma surgery devices.Below I will disclose my top 10 events for 2016, from my perspective. I would also like to thank the entire OSN team for keeping me in line and on time in order to make this Premier Channel column a reality every month.